Patents by Inventor Hongmin Liu

Hongmin Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240355851
    Abstract: A photoelectric sensor includes: a substrate with a light-receiving surface. The substrate includes a photosensitive pixel area and the photosensitive pixel area includes pixel unit areas distributed in a matrix. Light traps are located in a part of a thickness of the substrate in the pixel unit area. The light traps are located on the light-receiving surface of the substrate, and distributed in a matrix along a row direction and a column direction. The row direction is perpendicular to the column direction. Adjacent light traps in the column direction are connected, and adjacent light traps in the row direction are connected. Side walls of the plurality of light traps surround and form a plurality of protrusions. Adjacent protrusions are connected, and the plurality of protrusions has a shape of octagonal pyramid.
    Type: Application
    Filed: July 30, 2021
    Publication date: October 24, 2024
    Inventors: Hongmin LIU, Xinpeng WANG, Qiangwei CUI, Guilin FAN
  • Publication number: 20230387161
    Abstract: A photoelectric sensor and a method for forming same and an electronic device are provided. The photoelectric sensor includes: a base, having a light receiving surface and including a pixel unit region; and a plurality of light trapping grooves, arranged in a part of the base in a thickness direction in the pixel unit region and arranged on a side of the light receiving surface of the base, where a surface shape of each of the light trapping grooves is arcuate. The present disclosure helps improve photosensitive performance of the photoelectric sensor.
    Type: Application
    Filed: October 11, 2022
    Publication date: November 30, 2023
    Applicants: SEMICONDUCTOR MANUFACTURING INTERNATIONAL (BEIJING) CORPORATION, SEMICONDUCTOR MANUFACTURING INTERNATIONAL (SHANGHAI) CORPORATION
    Inventors: Hongmin LIU, Qiangwei CUI, Changcheng GAO
  • Publication number: 20220279787
    Abstract: The disclosure relates to the technical field of sterilizing and disinfecting materials, and specifically relates to an ?-substituted phenyl structure-containing compound, a preparation method thereof, and a disinfectant. The ?-substituted phenyl structure-containing compound according to the disclosure could achieve a bactericidal effect by promoting the coagulation and denaturation of the protein of pathogenic microorganisms. In particular, it has a good killing effect on pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Bacillus subtilis var. niger spores. Besides, it has no corrosive effect on metals, no irritating odor, good water solubility, and is green and environmentally friendly. Therefore, it could be widely used in various industries as an effective ingredient of a disinfectant.
    Type: Application
    Filed: June 24, 2020
    Publication date: September 8, 2022
    Inventors: Hongmin Liu, Bing Zhao, Shangshang Qin, Liying Ma, Kai Sun, Xuejian Feng, Wenge Guo, Guangyao Liu
  • Publication number: 20200338609
    Abstract: The present invention discloses a method for channel decoupling of a whole-roller flatness meter for a cold-rolled strip. The method includes the following steps: 1, setting a channel number and a channel breadth of the flatness meter; 2, obtaining an influence matrix under the condition of coupled channels; 3, calculating an inverse matrix of the influence matrix; 4, decoupling the channel by the inverse matrix of the influence matrix; and 5, obtaining flatness distribution after channel decoupling. The present invention decouples the channel of the whole-roller flatness meter by inverting the influence matrix and multiplying with the detection force vector. The present invention reproduces the true force vector and flatness distribution, and provides a new method for improving the flatness detection accuracy.
    Type: Application
    Filed: April 27, 2020
    Publication date: October 29, 2020
    Inventors: Hongmin Liu, Huaxin Yu, Dongcheng Wang, Yanghuan Xu, Tongyuan Zhang
  • Patent number: 9636324
    Abstract: Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: May 2, 2017
    Assignee: Zhengzhou University
    Inventors: Guifu Dai, Jing Zhao, Haiwei Xu, Huanfei Liu, Zhenwei Wu, Di Wu, Jian Wu, Hongmin Liu
  • Publication number: 20160279096
    Abstract: Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.
    Type: Application
    Filed: June 8, 2016
    Publication date: September 29, 2016
    Inventors: Guifu Dai, Jing Zhao, Haiwei Xu, Huanfei Liu, Zhenwei Wu, Di Wu, Jian Wu, Hongmin Liu
  • Patent number: 9388169
    Abstract: Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: July 12, 2016
    Assignee: Zhengzho University
    Inventors: Guifu Dai, Songlin Zhu, Yanan Wang, Jian Wu, Dan Zhao, Di Wu, Huanfei Liu, Haiwei Xu, Mengjiao Liu, Jing Zhao, Wei Han, Zhenwei Wu, Hang Wang, Hongmin Liu
  • Patent number: 9198894
    Abstract: The present invention relates to the preparation of anti-tumor drugs with andrographolide derivatives, which belongs to the field of pharmaceutical technology, and involves 15-benzylidene substituted derivatives of 14-deoxy-11,12-didehydro-andrographolide and their 3,19-ester derivatives. Proved by the experiments, these compounds significantly inhibited the colony formation and migration ability of various cancer cells, and also inhibited the migration ability of vascular endothelial cells in vitro. The compounds of this invention significantly inhibited the tumor growth, invasion, metastasis and angiogenesis on mouse xenograft models, and inhibited the experimental lung metastasis of B16-F10 malignant melanoma cells. Therefore, this class of compounds could be used as the active ingredients for the preparation of antineoplastic drugs, which are of efficiency and low-toxicity.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: December 1, 2015
    Assignee: Zhengzhou University
    Inventors: Fengjuan Wu, Guifu Dai, Haiwei Xu, Zhiwen Jiang, Liping Zhu, Lijun Yan, Hongmin Liu, Yanan Wang, Weiyi Li, Ruijing Dong
  • Publication number: 20150051403
    Abstract: Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.
    Type: Application
    Filed: February 5, 2013
    Publication date: February 19, 2015
    Applicant: ZHENGZHOU UNIVERSITY
    Inventors: Guifu Dai, Songlin Zhu, Yanan Wang, Jian Wu, Dan Zhao, Di Wu, Huanfei Liu, Haiwei Xu, Mengjiao Liu, Jing Zhao, Wei Han, Zhenwei Wu, Hang Wang, Hongmin Liu
  • Publication number: 20140187627
    Abstract: Disclosed is a use of C15-substituted andrographolide derivatives in preparation of anti-hepatitis B virus medicaments. In the present invention, the HepG2.2.15 cells are used to measure the amount of the hepatitis B virus surface antigen (HBsAg) secretion in the supernatant of the culture; the duck hepatitis B virus (DHBV) is used to infect the model and the DHBV-DNA level in serum is measured, and the pathological change in hepatic tissue is observed. A number of andrographolide derivative compounds are screened, compounds having a good anti-HBV effect are preferred, which has a structure represented by general formula 1 set forth herein. Due to high anti-HBV activity and low toxicity, as well as good protection against hepatic injury, the compounds can be used as the active ingredient for preparing anti-HBV medicaments, thereby providing a new pharmaceutical way for treatment of hepatitis, and broadening the range of clinical medicines.
    Type: Application
    Filed: July 3, 2012
    Publication date: July 3, 2014
    Applicant: ZHENGZHOU UNIVERSITY
    Inventors: Guifu DAI, Haiwei XU, Zhiwen JIANG, Hongmin LIU, Yanan WANG, Kuicheng ZHU, Zhenwei WU, Weiyi LI, Fengjuan WU, Mengjiao LIU, Wei HAN
  • Publication number: 20130237596
    Abstract: The present invention relates to the preparation of anti-tumor drugs with andrographolide derivatives, which belongs to the field of pharmaceutical technology, and involves 15-benzylidene substituted derivatives of 14-deoxy-11,12-didehydro-andrographolide and their 3,19-ester derivatives. Proved by the experiments, these compounds significantly inhibited the colony formation and migration ability of various cancer cells, and also inhibited the migration ability of vascular endothelial cells in vitro. The compounds of this invention significantly inhibited the tumor growth, invasion, metastasis and angiogenesis on mouse xenograft models, and inhibited the experimental lung metastasis of B16-F10 malignant melanoma cells. Therefore, this class of compounds could be used as the active ingredients for the preparation of antineoplastic drugs, which are of efficiency and low-toxicity.
    Type: Application
    Filed: October 19, 2011
    Publication date: September 12, 2013
    Applicant: ZHENGZHOU UNIVERSITY
    Inventors: Guifu Dai, Haiwei Xu, Liping Zhu, Ruijing Dong, Fengjuan Wu, Yanan Wang, Zhiwen Jiang, Lijun Yan, Weiyi Li, Hongmin Liu
  • Patent number: 8084430
    Abstract: Novel ent-kaurene diterpene compound and its derivatives, their preparation methods and their use. ent-Kaurene diterpene in the present invention could be used as desired intermediates for preparing asymmetric organic compounds and medicaments, and could be used as antitumor agent, anti-inflammatory agent and immune agent etc. The said ent-kaurene diterpene compound could be condensed with hydroxyl compounds to obtain various acetal derivatives, could be reacted with amine compounds to obtain various amino derivatives, and could be reacted with acyl halide or acid anhydride to obtain various acyl derivatives.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: December 27, 2011
    Assignees: Zhengzhou University, Furen Pharmaceutical
    Inventors: Hongmin Liu, Wenchen Zhu, Chenggong Zhu, Qingduan Wang, Yu Ke, Zhengzhou Liu, Xuebin Yan, Zhang Jianye, Hongli Qu
  • Publication number: 20100228014
    Abstract: Novel ent-kaurene diterpene compound and its derivatives, their preparation methods and their use. ent-Kaurene diterpene in the present invention could be used as desired intermediates for preparing asymmetric organic compounds and medicaments, and could be used as antitumor agent, anti-inflammatory agent and immune agent etc. The said ent-kaurene diterpene compound could be condensed with hydroxyl compounds to obtain various acetal derivatives, could be reacted with amine compounds to obtain various amino derivatives, and could be reacted with acyl halide or acid anhydride to obtain various acyl derivatives.
    Type: Application
    Filed: January 18, 2007
    Publication date: September 9, 2010
    Applicant: Zhengzhou University
    Inventors: Hongmin Liu, Wenchen Zhu, Chenggong Zhu, Qingduan Wang, Yu Ke, Zhengzhou Kiu, Xuebin Yan, Zhang Jianye, Hongli Qu
  • Patent number: D966472
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: October 11, 2022
    Inventor: Hongmin Liu
  • Patent number: D1034922
    Type: Grant
    Filed: March 24, 2023
    Date of Patent: July 9, 2024
    Inventor: Hongmin Liu